Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ), sold 2,296 shares at $140.76 ($323K) on 2023-03-05, disclosed to the SEC on 2023-03-07.
Seasonal sale ($323k) by SVP, Chief Accounting Officer — this insider has traded JAZZ in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.76 | 1,148 | $162K | 50.0% |
| 2 | $140.76 | 1,148 | $162K | 50.0% |
| Total | $140.76 avg | 2,296 | $323K | 100% |
| Filing → |
| JAZZ | SELL | 2025-12-09 | $798K | — | Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |